General Counterdrug Intelligence Plan
Appendix A – Applicable Legislation
The following highlights from applicable legislation summarize Counterdrug Technology Assessment Center appropriations, functions, staff levels and roles.
(f) For programs, projects or activities in the Treasury, Postal Service, and General Appropriations Act, 1997, provided as follows, to be effective as if it had been enacted into law as the regular appropriations Act:
"For necessary expenses of the Office of National Drug Control Policy; for research activities pursuant to title I of Public Law 100-690; not to exceed $8,000 for official reception and representation expenses; and for participation in joint projects or in the provision of services on matters of mutual interest with nonprofit, research, or public organizations or agencies, with or without reimbursement; $35,838,000, of which $19,000,000 shall remain available until expended, consisting of $1,000,000 for policy research and evaluation and $18,000,000 for the Counter-Drug Technology Assessment Center for counternarcotics research and development projects of which $1,000,000 shall be obligated for state conferences on model state drug laws: Provided, That the $17,000,000 for the Counter-Drug Technology Assessment Center shall be available for transfer to other Federal departments or agencies: Provided further, That the Office is authorized to accept, hold, administer, and utilize gifts, both real and personal, for the purpose of aiding or facilitating the work of the Office: Provided further, That not before January 31, 1997, the Director of the Office of National Drug Control Policy shall transfer all balances in the Special Forfeiture Fund established by section 6073 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. § 1509) to the Treasury Forfeiture Fund (31 U.S.C. 9703(a))."
-
P.L. 104-208 of September 30, 1996 – Making omnibus consolidated appropriations for the fiscal year ending September 30, 1997, and for other purposes.
"For necessary expenses of the Office of National Drug Control Policy; for research activities pursuant to title I of Public Law 100-690; ... $35,838,000, of which $19,000,000 shall remain available until expended, consisting of $1,000,000 for policy research and evaluation and $18,000,000 for the Counter-Drug Technology Assessment Center for counternarcotics research and development projects of which $1,000,000 shall be obligated for state conferences on model state drug laws: Provided, That the $17,000,000 for the Counter-Drug Technology Assessment Center shall be available for transfer to other Federal departments or agencies:"
-
Conference Report 105-284 of September 29, 1997, [To accompany H.R. 2378] Making Appropriations for the Treasury Department, The United States Postal Service, The Executive Office Of The President, and certain independent agencies, for the fiscal year ending September 30, 1998, and for other purposes
"For necessary expenses of the Office of National Drug Control Policy; for research activities pursuant to title I of Public Law 100- 690; not to exceed $8,000 for official reception and
representation expenses; and for participation in joint projects or in the provision of services on matters of mutual interest with nonprofit, research, or public organizations or agencies, with or without reimbursement; $35,016,000, of which $17,000,000 shall remain available until expended, consisting of $1,000,000 for policy research and evaluation and $16,000,000 for the Counterdrug Technology Assessment Center for counternarcotics research and development projects: Provided, That the $16,000,000 for the Counterdrug Technology Assessment Center shall be available for transfer to other Federal departments or agencies: Provided further, That the Office is authorized to accept, hold, administer, and utilize gifts, both real and personal, for the purpose of aiding or facilitating the work of the Office: Provided further, That not before December 31, 1997, the Director of the Office of National Drug Control Policy shall transfer all balances in the Special Forfeiture Fund established by section 6073 of the Anti-drug Abuse Act of 1988 (21 U.S.C. section 1509) to the Treasury Forfeiture Fund (31 U.S.C. section 9703(a))."
"The conferees provide $13,000,000 to the Counterdrug Technology Assessment Center (CTAC) of the Office of National Drug Control Policy (ONDCP) to establish a program for transferring technology directly to State and local law enforcement agencies. Since its inception, CTAC has worked with many law enforcement agencies and prosecutors to find technological solutions to critical law enforcement problems, and many valuable applications have been developed. The conferees direct that this new funding be used to initiate a pilot program to transfer these technologies directly to State and local law enforcement agencies who may otherwise be unable to profit from the developments due to limited budgets or a lack of technological expertise. The conferees direct CTAC to initiate this program under the direction of the Chief Scientist, ONDCP, with the advice of experts from State and local law enforcement, and in cooperation with High Intensity Drug Trafficking Area (HIDTA) programs to identify the technologies to be transferred and locations to be served. The conferees expect that priority will be given to identifying candidates for transfer in the currently designated HIDTAs, and expect that CTAC and HIDTA will also weigh the ability and willingness of potential recipients to share in the costs of new technology, either through in-kind or direct contributions. The conferees also direct the Chief Scientist to submit a report to the Committees on Appropriations evaluating the performance of the program not later than 18 months from the date of the first transfer, as well as a strategic plan for countrywide deployment of technology. Additionally, the Chief Scientist is directed to consult with the Committees on Appropriations prior to the obligation of these funds to ensure that the money appropriated is going toward providing State and local law enforcement agencies access to counterdrug technology and not unreasonable administrative or otherwise unintended purposes."
"The conferees agree to provide $35,016,000 instead of $43,516,000 as proposed by the House and $36,016,000 as proposed by the Senate. Of this amount, the conferees have included $16,000,000 for the basic program of the Counterdrug Technology Assessment Center, and $1,000,000 for policy research and evaluation. The conference agreement separately funds $13,000,000 for a new technology transfer program by the Counterdrug Technology Assessment Center, as well as $1,200,000 for model state drug law conferences, through the Violent Crime Reduction Trust Fund."
-
P.L. 105-61 of October 10, 1997 – Treasury, Postal Service, and General Government Appropriations of fiscal year ending September 30, 1998
"For necessary expenses of the Office of National Drug Control Policy; for research activities pursuant to title I of Public Law 100-690; ...$35,016,000, of which $17,000,000 shall remain available until expended, consisting of $1,000,000 for research and evaluation and $16,000,000 for the Counterdrug Technology Assessment Center for counternarcotics research and development projects: Provided, That the $16,000,000 for the Counterdrug Technology Assessment Center shall be available for transfer to other Federal departments or agencies:"
"For activities authorized by Public Law 103-322, to remain available until expended, which shall be derived from the Violent Crime Reduction Trust Fund, as follows:
(1) As authorized by section 19001(e), $131,000,000; ... of which $20,200,000 shall be available to the Office of National Drug Control Policy, including $13,000,000 to the Counterdrug Technology Assessment Center for a program to transfer technology to State and local law enforcement agencies, ..."
"(a) Report Requirement. — Not later than December 1st of each year, the Director of the Office of National Drug Control Policy shall submit to Congress and the President a report on the development and deployment of narcotics detection technologies by Federal Agencies. Each such report shall be prepared in consultation with the Secretary of Defense, the Secretary of State, the Secretary of Transportation, and the Secretary of Treasury."
(b) Matters To Be Included. — Each report under subsection (a) shall include –
(1) a description of each project implemented by a Federal agency relating to the development or deployment of narcotics detection technology;
(2) the agency responsible for each project described in paragraph (1);
(3) the amount of funds obligated or expended to carry out each project described in paragraph (1) during the fiscal year in which the report is submitted or during any fiscal year preceding the fiscal year in which the report is submitted;
(4) the amount of funds estimated to be obligated or expended for each project described in paragraph (1) during any fiscal year after the fiscal year in which the report is submitted to Congress; and
(5) a detailed timeline for implementation of each project described in paragraph (1).
Conference Report 105-760 of October 1, 1998 [to Accompany H.R. 4104] Appropriations For The Treasury Department, The United States Postal Service, The Executive Office Of The President, And Certain Independent Agencies, For The Fiscal Year Ending September 30, 1999
"For necessary expenses of the Office of National Drug Control Policy; for research activities pursuant to title I of Public Law 100-690; not to exceed $8,000 for official reception and
representation expenses; and for participation in joint projects or in the provision of services on matters of mutual interest with nonprofit, research, or public organizations or agencies, with or without reimbursement, $48,042,000, of which $30,100,000 shall remain available until expended, consisting of $1,100,000 for policy research and evaluation, and $16,000,000 for the counterdrug Technology Assessment Center for counternarcotics research and development projects, and $13,000,000 for the continued operation of the technology transfer program: Provided, That the $16,000,000 for the Counterdrug Technology Assessment Center shall be available for transfer to other Federal departments or agencies: Provided further, That the Office is authorized to accept, hold, administer, and utilize gifts, both real and personal, public and private, without fiscal year limitation, for the purpose of aiding or facilitating the work of the Office."
"The conferees agree to provide $2,500,000 for ONDCP, instead of $14,000,000 as proposed by the House and no funding as proposed by the Senate. $1,000,000 of this funding would cover the costs of continuing support for Model State Drug Law Conferences, as proposed by the House. $13,000,000 proposed by the House for continued funding for the technology transfer program run by the Counterdrug Technology Assessment Center will instead be funded in the ONDCP Salaries and Expenses account, as proposed by the Senate."
"The conferees agree to provide $48,042,000 for the Office of National Drug Control Policy (ONDCP) as proposed by the Senate, instead of $36,442,000 as proposed by the House. This includes $13,000,000 to continue the technology transfer pilot program managed by the Counterdrug Technology Assessment Center (CTAC). It also includes $17,942,000 for ONDCP operations, as proposed by the Senate, $16,000,000 for the basic CTAC program, and $1,100,000 for policy research of which $100,000 is to be used for evaluating the Drug-Free Communities Act, as proposed by the Senate. The conferees agree to modify language governing the authority of ONDCP to accept and use gifts. The conference agreement separately funds $1,000,000 for Model State Drug Law Conferences through the Violent Crime Reduction Trust Fund."
"The conferees expect the multiagency research and development programs to be coordinated by the Counterdrug Technology Assessment Center (CTAC) in order to prevent duplication of effort and to assure that, whenever possible, those efforts provide capabilities that transcend the need of any single Federal agency. Prior to obligation of these funds, the conferees expect to be notified by the chief scientist on how these funds will be spent. The conferees also expect to receive periodic reports from the chief scientist on the priority counterdrug enforcement research and development requirements identified by the Center and on the status of projects funded by CTAC."
-
Conference Report 105-789 of October 7, 1998 [To accompany H.R. 4104] Appropriations For The Treasury Department, The United States Postal Service, The Executive Office Of The President, and Certain Independent Agencies, For the Fiscal Year Ending September 30, 1999
"The conferees agree to provide $48,042,000 for the Office of National Drug Control Policy (ONDCP) as proposed by the Senate, instead of $36,442,000 as proposed by the House. This includes $13,000,000 to continue the technology transfer pilot program managed by the
Counterdrug Technology Assessment Center (CTAC). It also includes $17,942,000 for ONDCP operations, as proposed by the Senate, $16,000,000 for the basic CTAC program, and $1,100,000 for policy research of which $100,000 is to be used for evaluating the Drug-Free Communities Act, as proposed by the Senate. The conferees agree to modify language governing the authority of ONDCP to accept and use gifts. The conference agreement separately funds $1,000,000 for Model State Drug Law Conferences through the Violent Crime Reduction Trust Fund."
"The conferees expect the multiagency research and development programs to be coordinated by the Counterdrug Technology Assessment Center (CTAC) in order to prevent duplication of effort and to assure that, whenever possible, those efforts provide capabilities that transcend the need of any single Federal agency. Prior to obligation of these funds, the conferees expect to be notified by the chief scientist on how these funds will be spent. The conferees also expect to receive periodic reports from the chief scientist on the priority counterdrug enforcement research and development requirements identified by the Center and on the status of projects funded by CTAC."
"The conferees agree to provide $48,042,000 for the Office of National Drug Control Policy (ONDCP) as proposed by the Senate, instead of $36,442,000 as proposed by the House. This includes $13,000,000 to continue the technology transfer pilot program managed by the Counterdrug Technology Assessment Center (CTAC). It also includes $17,942,000 for ONDCP operations, as proposed by the Senate, $16,000,000 for the basic CTAC program, and $1,100,000 for policy research of which $100,000 is to be used for evaluating the Drug-Free Communities Act, as proposed by the Senate. The conferees agree to modify language governing the authority of ONDCP to accept and use gifts. The conference agreement separately funds $1,000,000 for Model State Drug Law Conferences through the Violent Crime Reduction Trust Fund."
"The conferees expect the multiagency research and development programs to be coordinated by the Counterdrug Technology Assessment Center (CTAC) in order to prevent duplication of effort and to assure that, whenever possible, those efforts provide capabilities that transcend the need of any single Federal agency. Prior to obligation of these funds, the conferees expect to be notified by the chief scientist on how these funds will be spent. The conferees also expect to receive periodic reports from the chief scientist on the priority counterdrug enforcement research and development requirements identified by the Center and on the status of projects funded by CTAC."
"For necessary expenses of the Office of National Drug Control Policy; for research activities pursuant to title I of Public Law 100-690; not to exceed $8,000 for official reception and representation expenses; and for participation in joint projects or in the provision of services on matters of mutual interest with nonprofit, research, or public organizations or agencies, with or
without reimbursement; $48,042,000, of which $30,100,000 shall remain available until expended, consisting of $1,100,000 for policy research and evaluation, and $16,000,000 for the Counterdrug Technology Assessment Center for counternarcotics research and development projects, and $13,000,000 for the continued operation of the technology transfer program: Provided, That the $16,000,000 for the Counterdrug Technology Assessment Center shall be available for transfer to other Federal departments or agencies: Provided further, That the Office is authorized to accept, hold, administer, and utilize gifts, both real and personal, public and private, without fiscal year limitation, for the purpose of aiding or facilitating the work of the Office."
- P.L. 105-277 of October 21, 1998 [H.R. 4328] (title VII of Division C) Office of National Drug Control Policy Reauthorization Act of 1998
SEC. 708. COUNTER-DRUG TECHNOLOGY ASSESSMENT CENTER.
(a) ESTABLISHMENT. – There is established within the Office
the Counter-Drug Technology Assessment Center (referred to in
this section as the ''Center''). The Center shall operate under the
authority of the Director of National Drug Control Policy and shall
serve as the central counter-drug technology research and development
organization of the United States Government.
(b) DIRECTOR OF TECHNOLOGY. – There shall be at the head
of the Center the Director of Technology, who shall be appointed
by the Director of National Drug Control Policy from among individuals
qualified and distinguished in the area of science, medicine,
engineering, or technology.
(c) ADDITIONAL RESPONSIBILITIES OF THE DIRECTOR OF
NATIONAL DRUG CONTROL POLICY. –
- (1) IN GENERAL. – The Director, acting through the Director
of Technology shall –
- (A) identify and define the short-, medium-, and long-term
scientific and technological needs of Federal, State,
and local drug supply reduction agencies, including-
- (i) advanced surveillance, tracking, and radar imaging;
- (ii) electronic support measures;
- (iii) communications;
- (iv) data fusion, advanced computer systems, and
artificial intelligence; and
- (v) chemical, biological, radiological (including neutron,
electron, and graviton), and other means of detection;
- (B) identify demand reduction basic and applied
research needs and initiatives, in consultation with affected
National Drug Control Program agencies, including-
- (i) improving treatment through neuroscientific
advances;
- (ii) improving the transfer of biomedical research
to the clinical setting; and
- (iii) in consultation with the National Institute
on Drug Abuse, and through interagency agreements
or grants, examining addiction and rehabilitation
research and the application of technology to expanding
the effectiveness or availability of drug treatment;
- (C) make a priority ranking of such needs identified
in subparagraphs (A) and (B) according to fiscal and
technological feasibility, as part of a National Counter-Drug
Enforcement Research and Development Program;
- (D) oversee and coordinate counter-drug technology initiatives
with related activities of other Federal civilian
and military departments;
- (E) provide support to the development and
implementation of the national drug control performance
measurement system; and
- (F) pursuant to the authority of the Director of
National Drug Control Policy under section 704, submit
requests to Congress for the reprogramming or transfer
of funds appropriated for counter-drug technology research
and development.
-
(2) LIMITATION ON AUTHORITY. – The authority granted to
the Director under this subsection shall not extend to the
award of contracts, management of individual projects, or other
operational activities.
(d) ASSISTANCE AND SUPPORT TO OFFICE OF NATIONAL DRUG
CONTROL POLICY. – The Secretary of Defense and the Secretary
of Health and Human Services shall, to the maximum extent practicable,
render assistance and support to the Office and to the
Director in the conduct of counter-drug technology assessment.
-
Conference Report 106-319 of September 14, 1999 [To accompany H.R. 2490] Making Appropriations for The Treasury Department, The United States Postal Service, The Executive Office Of The President, And Certain Independent Agencies, For The Fiscal Year Ending September 30, 2000, And For Other Purposes
"For necessary expenses for the Counterdrug Technology Assessment Center for research activities pursuant to the Office of National Drug Control Policy Reauthorization Act of 1998 (title VII of Division C of Public Law 105-277), $29,250,000, which shall remain available until expended, consisting of $16,000,000 for counternarcotics research and development projects, and $13,250,000 for the continued operation of the technology transfer program: Provided, That the $16,000,000 for counternarcotics research and development projects shall be available for transfer to other Federal departments or agencies."
"The conferees agree to provide $29,250,000 instead of $31,100,000 as proposed by the Senate. The House had proposed $29,250,000 in ONDCP's Salaries and Expenses Appropriation. The conferees agree to establish this new, separate appropriation account for the Counterdrug
Technology Assessment Center (CTAC) as authorized in Public Law 105-277 and proposed by the Senate. It consists of $16,000,000 for the core research and assessment activities of CTAC, as well as $13,250,000 for the counterdrug technology transfer program."
"For necessary expenses for the Counterdrug Technology Assessment Center for research activities pursuant to the Office of National Drug Control Policy Reauthorization Act of 1998 (titleVII of Division C of Public Law 105-277), $29,250,000, which shall remain available until expended, consisting of $16,000,000 for counternarcotics research and development projects, and $13,250,000 for the continued operation of the technology transfer program: Provided, That the $16,000,000 for counternarcotics research and development projects shall be available for transfer to other Federal departments or agencies."
Conference Report (H. Rept. 106-479) on H.R. 3194, Consolidated Appropriations Act, 2000 (House of Representatives – November 17, 1999)
Division B, Title II — Other Appropriations Matters
"Sec. 237. In addition to amounts appropriated to the Office of National Drug Control Policy, $3,000,000 is appropriated: Provided, That this amount shall be made available by grant to the United States Olympic Committee for its anti-doping program within 30 days of the enactment of this Act."
P.L. 106-113 of November 29, 1999: An act making consolidated appropriations for the fiscal year ending September 30, 2000, and for other purposes.
Division B, Appendix E, Title II — Other Appropriations Matters
"Sec. 237. In addition to amounts appropriated to the Office of National Drug Control Policy, $3,000,000 is appropriated: Provided, That this amount shall be made available by grant to the United States Olympic Committee for its anti-doping program within 30 days of the enactment of this Act."